Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Albuterol in HFpEF (BEAT HFpEF)
NCT02885636Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2016
- Primary completion
- Sep 2017
- Countries
- 1
01
Overview
A Phase 3 trial of albuterol dry powder inhaler in heart failure with preserved ejection fraction (HFpEF), sponsored by Mayo Clinic. Started Sep 2016; status: completed.
02
Drugs
albuterol dry powder inhaler
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT02885636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02885636.